(19)
(11) EP 4 815 810 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898655.6

(22) Date of filing: 26.11.2024
(51) International Patent Classification (IPC): 
A61B 3/14(2006.01)
G06N 3/08(2023.01)
G06V 10/82(2022.01)
A61B 3/12(2006.01)
G06V 40/19(2022.01)
(52) Cooperative Patent Classification (CPC):
G06V 10/82; A61B 3/12; G06N 3/08; A61B 3/14; G06N 20/00; G06N 20/20; G06N 5/01; G06N 3/09; G06V 2201/03; G06V 10/764; G06V 40/193; G06V 40/197
(86) International application number:
PCT/US2024/057512
(87) International publication number:
WO 2025/117574 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605148 P

(71) Applicants:
  • Memorial Sloan Kettering Cancer Center
    New York, NY 10065 (US)
  • Memorial Hospital for Cancer and Allied Diseases
    New York, NY 10065 (US)
  • Sloan-kettering Institute For Cancer Research
    New York, NY 10065 (US)

(72) Inventors:
  • CRUZ-ABRAMS, Owen
    New York, New York 10065 (US)
  • ABRAMSON, David
    New York, New York 10065 (US)

(74) Representative: Barker Brettell LLP 
100 Hagley Road Edgbaston
Birmingham, West Midlands B16 8QQ
Birmingham, West Midlands B16 8QQ (GB)

   


(54) SYSTEMS AND METHODS FOR DETECTING RETINOBLASTOMA